NASDAQ:RLAY

Relay Therapeutics Stock Predictions

etoro logo Buy RLAY
*Your capital is at risk
$15.30
-0.400 (-2.55%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

RLAY Prediction Chart

RLAY Predictions History

Latest community submissions for RLAY.
Predictor Target Session Target Price Result Direction Accuracy Score
May 29, 2026 $13.55 -2.52% $14.05 X 96.44% 0
May 29, 2026 $13.50 -2.88% $14.05 X 96.09% 0
May 29, 2026 $13.65 -1.80% $14.05 X 97.15% 0
May 29, 2026 Bullish $14.05 X 1
Mar 11, 2025 $3.40 +3.88% $3.47 V 97.90% 1
Mar 11, 2025 $3.35 +2.43% $3.47 V 96.52% 1
Mar 11, 2025 Bullish $3.47 V 1
Mar 10, 2025 $3.33 -3.73% $3.27 V 98.13% 1
Mar 10, 2025 $3.38 -2.33% $3.27 V 96.65% 1
Mar 10, 2025 Bullish $3.27 X 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for RLAY with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT RELAY THERAPEUTICS INC.
Relay Therapeutics
Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhibitor of fibroblast growth factor receptor 2 (FGFR2), which is in a first-in-human clinical trial for pa...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE